These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36569524)

  • 41. Safety and Effectiveness of a New Blue Light Device for the Self-treatment of Mild-to-moderate Acne.
    Wheeland RG; Koreck A
    J Clin Aesthet Dermatol; 2012 May; 5(5):25-31. PubMed ID: 22808306
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination blue (415 nm) and red (633 nm) LED phototherapy in the treatment of mild to severe acne vulgaris.
    Goldberg DJ; Russell BA
    J Cosmet Laser Ther; 2006 Jun; 8(2):71-5. PubMed ID: 16766484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne.
    Dréno B; Bissonnette R; Gagné-Henley A; Barankin B; Lynde C; Chavda R; Kerrouche N; Tan J
    Am J Clin Dermatol; 2019 Oct; 20(5):725-732. PubMed ID: 31209851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
    Jurairattanaporn N; Chalermchai T; Ophaswongse S; Udompataikul M
    J Med Assoc Thai; 2017 Jan; 100(1):78-85. PubMed ID: 29911775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
    Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in an Asian Population.
    Han G; Armstrong AW; Desai SR; Guenin E
    J Drugs Dermatol; 2019 Sep; 18(9):910-916. PubMed ID: 31524347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Significant improvement in mild acne following a twice daily application for 6 weeks of an acidic cleansing product (pH 4).
    Abels C; Reich H; Knie U; Werdier D; Lemmnitz G
    J Cosmet Dermatol; 2014 Jun; 13(2):103-8. PubMed ID: 24910273
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and benzoyl peroxide (3.75%) aqueous gel in moderate or severe adolescent acne vulgaris.
    Cook-Bolden FE
    J Clin Aesthet Dermatol; 2015 May; 8(5):28-32. PubMed ID: 26029332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older.
    Tyring SK; Kircik LH; Pariser DM; Guenin E; Bhatt V; Pillai R
    J Drugs Dermatol; 2018 Oct; 17(10):1084-1091. PubMed ID: 30365589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multicentre, randomized, single-blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients.
    Xu JH; Lu QJ; Huang JH; Hao F; Sun QN; Fang H; Gu J; Dong XQ; Zheng J; Luo D; Li FQ; Wang G; Gu H; Tian HQ; Yang HL; Xi LY; Li M; Zheng M; Wu Y; Tu YT; He YL; Zhao G; Sheng WX; Li J; Hamedani AG
    J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1176-82. PubMed ID: 27075705
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Once-daily Dapsone 7.5% Gel for the Treatment of Acne Vulgaris in Preadolescent Patients: A Phase IV, Open-label, 12-week Study.
    Moore AY; Lain EL; McMichael A; Kircik L; Zaenglein AL; Hebert AA; Grada A
    J Clin Aesthet Dermatol; 2021 Apr; 14(4):43-48. PubMed ID: 34055189
    [No Abstract]   [Full Text] [Related]  

  • 52. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
    Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
    Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patient-Reported Outcomes in Acne Patients With Skin of Color Using Adapalene 0.3%-Benzoyl Peroxide 2.5%: A Prospective Real-World Study.
    DuBois J; Ong GCW; Petkar G; Almeida LMC; Chavda R; Kerrouche N; Alexis AF
    J Drugs Dermatol; 2019 Jun; 18(5):514. PubMed ID: 31251543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies.
    Feldman SR; Werner CP; Alió Saenz AB
    J Drugs Dermatol; 2013 Apr; 12(4):438-46. PubMed ID: 23652892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of treatment efficacy and sebosuppressive effect of fractional radiofrequency microneedle on acne vulgaris.
    Lee KR; Lee EG; Lee HJ; Yoon MS
    Lasers Surg Med; 2013 Dec; 45(10):639-47. PubMed ID: 24249246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-Severe Acne Vulgaris in an Adult and Adolescent Female Population.
    Kircik LH; Baldwin H; Lain E; Guenin E; Harris S; Bhatt V
    J Drugs Dermatol; 2019 Feb; 18(2):178-188. PubMed ID: 30811141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A split face study on the effect of an anti-acne product containing fermentation products of Enterococcus faecalis CBT SL-5 on skin microbiome modification and acne improvement.
    Han HS; Shin SH; Choi BY; Koo N; Lim S; Son D; Chung MJ; Park KY; Sul WJ
    J Microbiol; 2022 May; 60(5):488-495. PubMed ID: 35286606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study of the efficacy and tolerability of 0.04% tretinoin microsphere gel for preadolescent acne.
    Eichenfield LF; Matiz C; Funk A; Dill SW
    Pediatrics; 2010 Jun; 125(6):e1316-23. PubMed ID: 20498178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF; Alió Sáenz AB
    J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Single-center, open-label study of a proprietary topical 0.5% salicylic acid-based treatment regimen containing sandalwood oil in adolescents and adults with mild to moderate acne.
    Moy RL; Levenson C; So JJ; Rock JA
    J Drugs Dermatol; 2012 Dec; 11(12):1403-8. PubMed ID: 23377508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.